Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
60 patients with major depression will be treated with 10 mg Olanzapine or Placebo for 2
weeks. In case of response (reduction of depressive symptoms)the study will be continued for
further 60 days.